| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $53.2M | -23.6% |
| R&D Expense | $111.6M | -2.2% |
| SG&A Expense | $42.8M | +9.4% |
| Operating Income | -$101.3M | -21.0% |
| Pre-tax Income | -$99.3M | -18.8% |
| Income Tax | $0 | — |
| Net Income | -$99.3M | -18.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $193.7M | -5.8% |
| Accounts Receivable | $36.0M | +4455.2% |
| Current Assets | $237.1M | -23.6% |
| Total Assets | $260.9M | -23.1% |
| Current Liabilities | $152.6M | +43.5% |
| Total Liabilities | $346.6M | +38.6% |
| Stockholders' Equity | -$85.8M | -195.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$110.8M | +6.9% |
| Capital Expenditures | $1.7M | +8.1% |
| Investing Cash Flow | $98.3M | +336.9% |
| Financing Cash Flow | $648K | -99.4% |
| Free Cash Flow | -$112.5M | +6.7% |